This is filed to report hemolysis and recurrent mitral regurgitation.It was reported that this was a mitraclip procedure to treat degenerative mitral regurgitation (mr) with a grade of 4.On (b)(6) 2021, one clip was successfully deployed, reducing mr to 3+.There were no adverse patient effects and no clinically significant delay in the procedure.Then on an unknown date, prior to discharge, the patient possibly experienced a mitraclip induced hemolysis and mr increased to 4.The clip remains stable on both leaflets.Additional treatment was not provided.No additional information was provided.
|
The device is not returned.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the information reviewed, a definitive cause for the reported patient effects could not be determined in this case.Hemolysis and mitral regurgitation (mr) are listed in the instructions for use as a known possible complication associated with mitraclip procedures.Although a conclusive cause for the reported patient effects and the relationship to the device, if any, cannot be determined, there is no indication of a product issue with respect to manufacture, design or labeling.
|